Gregor Wollensak1, Elena Iomdina. 1. Department of Ophthalmology, Eye Laser Institute, Martin-Luther-University, Halle, Germany. gwollens@hotmail.com
Abstract
PURPOSE: To test the biomechanical efficiency of corneal crosslinking with riboflavin without epithelial debridement (C3-R). SETTING: Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia. METHODS: The left eyes of rabbits were crosslinked using standard crosslinking including epithelial removal (Group 1), using benzalkonium chloride-containing proxymetacaine eyedrops without epithelial removal (Group 2), or using preservative-free oxybuprocaine eyedrops without epithelial removal (Group 3). All left eyes received riboflavin solution and were irradiated with an ultraviolet-A double diode for 30 minutes (irradiance 3 mW/cm(2)). The animals were killed 1 day after crosslinking. Biomechanical and histological analyses were performed. RESULTS: Fourteen eyes were evaluated. There was a statistically significant increase in Young's modulus in Group 1 (102.45%) and in Group 2 (21.30%). In Group 3, no biomechanical changes were measured. Histology showed complete cell loss of keratocytes and endothelium in Group 1 and inhomogeneous keratocyte loss down to 200.0 microm in Group 2. No changes were observed in Group 3. CONCLUSIONS: Corneal crosslinking without epithelial debridement reduced the biomechanical effect by approximately one fifth compared with standard crosslinking, probably because of restricted and inhomogeneous stromal distribution of riboflavin. The cytotoxic damage was restricted to 200.0 microm stromal depth, which is an advantage over the standard method. Therefore, C3-R is not recommended for the routine treatment of keratoconus but primarily for cases with a corneal thickness less than 400.0 microm in which standard crosslinking cannot be used without serious risk to the endothelium.
PURPOSE: To test the biomechanical efficiency of corneal crosslinking with riboflavin without epithelial debridement (C3-R). SETTING: Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia. METHODS: The left eyes of rabbits were crosslinked using standard crosslinking including epithelial removal (Group 1), using benzalkonium chloride-containing proxymetacaine eyedrops without epithelial removal (Group 2), or using preservative-free oxybuprocaine eyedrops without epithelial removal (Group 3). All left eyes received riboflavin solution and were irradiated with an ultraviolet-A double diode for 30 minutes (irradiance 3 mW/cm(2)). The animals were killed 1 day after crosslinking. Biomechanical and histological analyses were performed. RESULTS: Fourteen eyes were evaluated. There was a statistically significant increase in Young's modulus in Group 1 (102.45%) and in Group 2 (21.30%). In Group 3, no biomechanical changes were measured. Histology showed complete cell loss of keratocytes and endothelium in Group 1 and inhomogeneous keratocyte loss down to 200.0 microm in Group 2. No changes were observed in Group 3. CONCLUSIONS: Corneal crosslinking without epithelial debridement reduced the biomechanical effect by approximately one fifth compared with standard crosslinking, probably because of restricted and inhomogeneous stromal distribution of riboflavin. The cytotoxic damage was restricted to 200.0 microm stromal depth, which is an advantage over the standard method. Therefore, C3-R is not recommended for the routine treatment of keratoconus but primarily for cases with a corneal thickness less than 400.0 microm in which standard crosslinking cannot be used without serious risk to the endothelium.
Authors: Elena Lanchares; María Angeles del Buey; José Angel Cristóbal; Laura Lavilla; Begoña Calvo Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-04-15 Impact factor: 3.117
Authors: Ricardo Lamy; Elliot Chan; Hui Zhang; Vasant A Salgaonkar; Sam D Good; Travis C Porco; Chris J Diederich; Jay M Stewart Journal: Invest Ophthalmol Vis Sci Date: 2013-08-28 Impact factor: 4.799
Authors: Settimio Rossi; Carmine Santamaria; Rosa Boccia; Luigi De Rosa; Francesco Maria D'Alterio; Francesca Simonelli; Giuseppe De Rosa Journal: Int Ophthalmol Date: 2017-11-28 Impact factor: 2.031
Authors: Alberto Artola; David P Piñero; Pedro Ruiz-Fortes; Roberto Soto-Negro; Rafael J Pérez-Cambrodí Journal: Int J Ophthalmol Date: 2017-04-18 Impact factor: 1.779
Authors: George D Kymionis; Michael A Grentzelos; Alexandra E Karavitaki; George A Kounis; Georgios A Kontadakis; Sonia Yoo; Ioannis G Pallikaris Journal: J Ophthalmol Date: 2010-11-02 Impact factor: 1.909